Advanced Search

Technical Analysis for SNOA - Sonoma Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 4.7 -12.15% -0.65
SNOA closed down 12.15 percent on Friday, March 27, 2020, on approximately normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
0 Watchers
Watchlist Portfolio

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical SNOA trend table...
Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
200 DMA Resistance Bearish -12.15%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -12.15%
Calm After Storm Range Contraction -12.15%
Inside Day Range Contraction -12.15%
Wide Bands Range Expansion -12.15%
Older EOD signals for SNOA ...
View Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators
SNOA Chart by TradingView
Basic chart:

Profile

Sonoma Pharmaceuticals operates as a pharmaceutical company. It develops and markets solutions for the treatment of dermatological conditions, animal health and advanced tissue care. The company operates primarily in United States, Latin America and Europe. Sonoma Pharmaceuticals formerly known as Oculus Innovative Sciences and is headquatered in Petaluma, California.
Health Pharmaceutical California Pharmaceutical Industry In China

Is SNOA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Feb 27 Sonoma Pharmaceuticals Announces Asset Purchase Agreement with Middle East Partner MicroSafe Group
Feb 14 Sonoma Pharmaceuticals reports Q3 results
Feb 14 Sonoma Pharmaceuticals Reports Third Quarter FY 2020 Financial Results
Jan 29 Is Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) A Volatile Stock?
Jan 24 Mid-Day Market Update: U.S. Stocks Turn Negative; Sonoma Pharmaceuticals Shares Surge
Jan 24 Healthcare - Top 5 Gainers / Losers
Jan 24 Sonoma Pharma up 20% premarket on potential sale of U.S. dermatology unit
Jan 24 The Daily Biotech Pulse: FDA Nod For Epizyme, Sonoma Explores Options For Dermatology Business, Roche's Cancer Drug Flunks Study
Jan 24 3 Drug Manufacturers—Specialty & Generic Stocks Moving In Thursday's After-Market Session
Jan 24 20 Healthcare Stocks Moving In Thursday's After-Market Session
See more SNOA news...

Indicators

Indicator Value
52 Week High 9.54
52 Week Low 3.33
Average Volume 28,897
200-Day Moving Average 5.63
50-Day Moving Average 5.17
20-Day Moving Average 5.01
10-Day Moving Average 4.85
Average True Range 0.78
ADX 20.98
+DI 20.55
-DI 18.57
Chandelier Exit (Long, 3 ATRs ) 4.17
Chandelier Exit (Short, 3 ATRs ) 5.88
Upper Bollinger Band 6.27
Lower Bollinger Band 3.76
Percent B (%b) 0.37
BandWidth 50.04
MACD Line 0.00
MACD Signal Line -0.05
MACD Histogram 0.0531
Fundamentals Value
Market Cap 20.24 Million
Num Shares 4.31 Million
EPS 1.96
Price-to-Earnings (P/E) Ratio 2.40
Price-to-Sales 1.34
Price-to-Book 1.01
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.08
Resistance 3 (R3) 6.19 5.83 5.85
Resistance 2 (R2) 5.83 5.48 5.78 5.77
Resistance 1 (R1) 5.27 5.26 5.09 5.16 5.70
Pivot Point 4.91 4.91 4.83 4.86 4.91
Support 1 (S1) 4.35 4.56 4.17 4.24 3.70
Support 2 (S2) 3.99 4.34 3.94 3.63
Support 3 (S3) 3.43 3.99 3.55
Support 4 (S4) 3.32